556 related articles for article (PubMed ID: 10908022)
1. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
[TBL] [Abstract][Full Text] [Related]
2. Clinical presentations, prognostic factors, and mortality in patients with Aeromonas sobria complex bacteremia in a teaching hospital: a 5-year experience.
Wang JH; Wang CY; Chi CY; Ho MW; Ho CM; Lin PC
J Microbiol Immunol Infect; 2009 Dec; 42(6):510-5. PubMed ID: 20422137
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
[TBL] [Abstract][Full Text] [Related]
4. Cephalosporin therapeutics for intensive care infections.
Salacata A; Chow JW
New Horiz; 1993 May; 1(2):181-6. PubMed ID: 7922401
[TBL] [Abstract][Full Text] [Related]
5. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
Chen SC; Lawrence RH; Byth K; Sorrell TC
Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Scand J Infect Dis; 2011 Mar; 43(3):202-8. PubMed ID: 21142623
[TBL] [Abstract][Full Text] [Related]
8. Community-acquired bacteraemia and antibiotic resistance. Trends during a 17-year period in a Danish county.
Pedersen G; Schønheyder HC; Kristensen B; Sørensen HT
Dan Med Bull; 2000 Sep; 47(4):296-300. PubMed ID: 11064832
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
Cheong HS; Kang CI; Kwon KT; Heo ST; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
J Antimicrob Chemother; 2007 Dec; 60(6):1355-60. PubMed ID: 17923453
[TBL] [Abstract][Full Text] [Related]
11. Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy.
Corona A; Wilson AP; Grassi M; Singer M
J Antimicrob Chemother; 2004 Oct; 54(4):809-17. PubMed ID: 15375106
[TBL] [Abstract][Full Text] [Related]
12. Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance.
Shaked H; Carmeli Y; Schwartz D; Siegman-Igra Y
Scand J Infect Dis; 2006; 38(11-12):995-1000. PubMed ID: 17148067
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study.
Khan FY; Elshafie SS; Almaslamani M; Abu-Khattab M; El Hiday AH; Errayes M; Almaslamani E
Travel Med Infect Dis; 2010 Nov; 8(6):377-87. PubMed ID: 21074495
[TBL] [Abstract][Full Text] [Related]
15. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom.
Ispahani P; Pearson NJ; Greenwood D
Q J Med; 1987 May; 63(241):427-40. PubMed ID: 3310074
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia.
Lee HC; Chuang YC; Yu WL; Lee NY; Chang CM; Ko NY; Wang LR; Ko WC
J Intern Med; 2006 Jun; 259(6):606-14. PubMed ID: 16704562
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
Chang EP; Chiang DH; Lin ML; Chen TL; Wang FD; Liu CY
J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
[TBL] [Abstract][Full Text] [Related]
18. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.
Ariza X; Castellote J; Lora-Tamayo J; Girbau A; Salord S; Rota R; Ariza J; Xiol X
J Hepatol; 2012 Apr; 56(4):825-32. PubMed ID: 22173153
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic therapy for gram-negative bacteremia.
Calandra T; Cometta A
Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
